How long does Pemvidutide take to work?
In the first week of Pemvidutide, appetite drops. Mild nausea. Slight body-temp uptick from glucagon arm. Around week 4, first titration step. Weight loss tracking. By week 8, phase 2 showed liver-fat reduction beginning to compound. Response varies between people, this is the commonly reported pattern, not a guarantee.
Week by week
- Week 1: Appetite drops. Mild nausea. Slight body-temp uptick from glucagon arm.
- Week 4: First titration step. Weight loss tracking.
- Week 8: Phase 2 showed liver-fat reduction beginning to compound.
References
- Pemvidutide for the treatment of NAFLD/NASH, Phase 1b — Altimmune Phase 1b readout, 2023
- Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: a randomized, double-blind, placebo-controlled study — Harrison SA et al., Journal of Hepatology, 2025
- Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis — Noureddin M et al., The Lancet, 2025
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Pemvidutide
Last updated 2026-06-06.